ipamorelin growth hormone secretagogue ghrelin receptor Secretagogues Explained: GHRH Analogs, GHRPs, and Mimetics The ups and downs of

Both groups received identical 100 mcg doses of Ipamorelin combined with a GHRH analog

As a triple incretin receptor agonist, it: Activates GLP-1 receptors , reducing appetite, slowing gastric emptying, and improving insulin secretion Activates GIP receptors , enhancing insulin response and potentially supporting fat metabolism Activates glucagon receptors , increasing energy expenditure and hepatic glucose output Whilst glucagon receptor activation increases hepatic glucose output, the net glycaemic effect of retatrutide is mitigated by the concurrent GLP-1 and GIP activity, resulting in overall improvements in glycaemic control in trial participants

Its clean receptor profile and short half-life make it ideal for pulsatile GH secretion research

References New England Journal of Medicine (2023) Triple-Hormone-Receptor Agonist Retatrutide for Obesity (Phase 2 trial

In turn, it will produce more healthy peptides and amino acids